About GPC Biotech
GPC Biotech's mission was to discover and develop novel anti-cancer drugs. The founding team raised two private financing rounds in 1997 and 1999, acquired a Boston-based drug discovery company, took GPC public in 2000 and listed GPC on Nasdaq in 2004. It developed an anti-cancer drug through clinical phase 3 and filed for market registration. In 2009, GPC Biotech merged with the US-based company Agennix Inc.
- Focus : Manufacturer
- Industry : Pharma
Product portfolio of GPC Biotech
News about GPC Biotech
Here you will find GPC Biotech AG
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
